Cardiorespiratory Training and Ventilatory Muscle Strength

Sarcopenia Clinical Trial

— RMS  

Official title:

Chronic Effect of Cardiorespiratory Training on Ventilatory Muscle Strength in Elderly Women: Controlled Trial, Randomized and Double Blind.

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT01912482
• Other study ID #: BR20132014
• Status: Not yet recruiting
• Phase: N/A
• First received: June 3, 2013
• Last updated: January 3, 2015
• Start date: July 2015
• Est. completion date: December 2016

Study information

• Verified date: January 2015
• Source: Universidade Gama Filho
• Contact: Fabio D Pereira, MSc
• Phone: 552178705024
• Email: profabiodutra[@]hotmail.com
• Is FDA regulated: No
• Health authority: Brazil: National Committee of Ethics in Research
• Study type: Interventional

Clinical Trial Summary

The cardiorespiratory training can increase muscle strength ventilatory.

Description:

Specifically for being an experiment parallel factorial intervention after met the eligibility criteria for the participants will be randomly allocated to three groups: control, respiratory training, cardiorespiratory training (indoor Bike).

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: December 2016
• Est. primary completion date: June 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 60 Years to 79 Years

Eligibility

Inclusion Criteria:

• Have lower maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) values normative reference proposed by the Brazilian Society of Thoracic.

Exclusion Criteria:

• Not be voluntary to the present study.

• Conditions that oblige participants are absent for more than two weeks of activities performed in the experiment.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Sarcopenia

Intervention

Other:
• Cardiorespiratory training
The cardiorespiratory training group will undergo 18 sessions, these also periodized in a maximum six weeks, respecting the minimum weekly frequency of 3 sessions.
• ventilatory training
The ventilatory training group will undergo 18 sessions, periodized in a maximum six weeks, respecting the minimum weekly frequency of three sessions.

Locations

Country	Name	City	State
Brazil	Gama Filho University	Rio de Janeiro	RJ

Sponsors (1)

Lead Sponsor	Collaborator
Universidade Gama Filho

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Ventilatory muscle strength	The MIP and MEP are measured by a digital manometer 300(BRAZIL). During the measurement the participants should be seated in a chair type office allowing your upper body to remain in contact with the back of it, forming an angle of 90° to the hip, the arms extended along the body, knees flexed too 90° and feet flat on the floor. Participants will use a nose clip.; The evaluator will manually compress the face of the participant not allowing the contraction of the buccinator muscles increase intraoral pressure and interfere with the measurement result.; In the measurement of MIP participants should hold a maximum inspiration from residual volume (RV) and MEP maximum exhalation from total lung capacity (TLC).	The ventilatory muscle strength (MIP and MEP) will be measured after 18 cardiorespiratory training sessions held in 6 weeks.	Yes